Literature DB >> 103999

Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice.

R H Kimberlin, C A Walker.   

Abstract

The intracerebral (i.c.) injection of mice with a particular source of hamster passaged scrapie produced disease after an incubation period of 325 +/- 6 days (mean +/- s.e.). The incubation period at the second i.e. passage in mice was reduced to 149 +/- 2 days. Studies were made of the dynamics of agent replication at 1st and 2nd passages in mice. At first passage, there was a 'zero phase' lasting about 175 days, when no infectious agent was detected in brain (or spleen), followed by a period of agent replication which lasted 150 days. At second passage, there was no significant 'zero phase' and agent replication occupied the whole of the incubation period. The occurrence of a 'zero phase' on interspecies passage of scrapie is discussed in relation to other reports of a 'zero phase' in mouse passaged scrapie.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 103999     DOI: 10.1099/0022-1317-42-1-107

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

2.  Correlation analysis for the incubation period of prion disease.

Authors:  Se-Eun Bae; Sunghoon Jung; Ha-Yeon Kim; Hyeon S Son
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

3.  Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.

Authors:  J C Bartz; R A Bessen; D McKenzie; R F Marsh; J M Aiken
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 5.  Prion diseases.

Authors:  Edward McKintosh; Sarah J Tabrizi; John Collinge
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

6.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Species-barrier-independent prion replication in apparently resistant species.

Authors:  A F Hill; S Joiner; J Linehan; M Desbruslais; P L Lantos; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.

Authors:  R Race; A Raines; G J Raymond; B Caughey; B Chesebro
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 9.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

10.  Prion interference is due to a reduction in strain-specific PrPSc levels.

Authors:  Jason C Bartz; Michelle L Kramer; Meghan H Sheehan; Jessica A L Hutter; Jacob I Ayers; Richard A Bessen; Anthony E Kincaid
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.